Pay in 4 interest-free payments of $5.30 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
A recent study found that GLP-1 drugs like Ozempic and Wegovy may improve breast cancer survival and recurrence in those with obesity and related health conditions
The patient is in early treatment
GLP-1 medications including semaglutide and tirzepatide are not banned by World Anti-Doping Agency
Message your provider Have a question between consults
Contact your GP or diabetes specialist if you experience : Persistent nausea or vomiting after restarting GLP-1 medication Difficulty maintaining adequate nutrition or hydration Unexplained abdominal pain or bloating Blood glucose levels outside your target range Your healthcare team will provide individualised guidance based on your specific circumstances, ensuring that resumption of GLP-1 therapy supports both your diabetes management goals and surgical recovery
US$ 21.83
US$ 22.96
US$ 27.74
